1Yu.-f S, Islam S, Chow CK, et a drugs fo cardiovascular disease in ore, middle - inome, and lov,, - Use of secondary prevention the communily in high - in- ineome countries ( the PURE Sldy) : a prospeelive epidemiological [ J ] . Lancet, 2011, 378 (9798) :1231 -43.
2Dcmgqi Xing, Susan Nozel, Yiu - Fai Chen, et al. Estrogen and Mhanisms of Vas ula Protection [ J ]. Arterioscler Thromb Vasc Bio1,2009,29 ( 3 ) :289 - 295.
3Simoncini T. Mechanisms of action of estrogen receptors in vascular ,ells : relevanc'e l, menopause and aging [ J ] Climacteric, 2009, 12(1):6--11.
4Ioh S, l lerna ndez- Daz S, Logan R, et al. Coronary heart disease in postmennpausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear A randomized trial [ J].Ann Intern Med,2010(152) :211 -217.
5Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hor- mone therapy and risk of cardiovascular disease by age and years since menopause [ J ]. JAMA,2007 ( 297 ) : 1465 - 1477.
6LaCroix AZ, Chlebowski RT, Manson JE, et al. For the WHI Inves- tigators. Health outcomes "after stopping conjugated equine estro- gens anmng postmenopausal women with prior hysterectomy : a ran- domized controlled trial [ J ]. JAMA, 2011 ( 305 ) : 1305 - 1314.
7Grodstein F, Manson JE, ColditzgA, et al. A prospective, observa- tional study of postmenopausal hormone therapy and primary pre- vention of cardiovascular disease [J ] . Ann Intern Med, 2000 ( 133 ) :933 -941.
8Chlebowski RT, Hendrix SL, Langer RD, et al. For the WHI Inves- tigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women : the Women ' s Health Initiative Randomized Trial [ J ] . JAMA, 2003 ( 289 ) : 3243 - 3253.
9Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replace- ment therapy and endometrial cancer risk:a meta -analysis [ J ]. Obstetgynecol, 1995 ( 85 ) :304 - 313.
10Canonico M, Oger E, Plu - Bureaug, et al. For the Estrogen and Thromboembolism Risk (ESTHER) Studygroup. Hormone therapy and venous thromboembolism among postmenopausal women [ J ]. Cireu - lation ,2007 ( 115 ) :840 - 845.
5Gall I, Visvanathan K, Millers R, et al. Body mass, estrogen levels, and hot flushes in midlife women[ J ]. Am J Obstet Gynecol,2005,193(4) :1353 -1360.
6Taylor M. Psychological consequences of surgical menopause[ J]. J Re- pord Med, 2001, 46(Suppl):317-324.
7Davis SR, Briganti EM, Chen RQ, et al. The effects of Chinese me- dicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial [ J]. Med J Aust, 2001,174 (2) :68-71.
8Sluijs CP, Bensoussan A, Chang S, et al. A randomized placebo-con- trolled trial on the effectiveness of an herbal formula to alleviate meno- pausal vasomotor symptoms[ J ]. Menopause, 2009, 16 ( 2 ) :336-344.
9Haines CJ, Lain PM, Chung TKH, et al. A randomized, double- blind, placebo-controlled study of the effect of a Chinese herbal medi- cine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women[ J]. Climacteric,2008,11 (3) :244-251.
10Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmeno- pausal women: the Women's Health Initiative Randomized Trial[ J]. JAMA, 2003,289(24) :3243-3253.
